Compare Novartis AG (NVS) vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF (VTIP) Price & Performance

Novartis AGTrade

Vanguard Sht-Term Inflation-Protected Sec Idx ETFTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $49.65. The key difference: Novartis AG pays a 3.17% dividend while Vanguard Sht-Term Inflation-Protected Sec Idx ETF pays none, and Novartis AG is trading nearer its 52-week high, Vanguard Sht-Term Inflation-Protected Sec Idx ETF nearer its low. Which is the better fit depends on your goals.

	NVS	VTIP
Market Cap	$290.25B	—
Sector	Health	—
52-Week High	$168.62	$50.75
52-Week Low	$113.50	$49.39
Enterprise Value	$330.27B	—
Dividend Yield	3.17%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 1 day agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 5 days agoBullish View details →

VTIP

View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Vanguard Sht-Term Inflation-Protected Sec Idx ETF

The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.